Glucagon-like peptide-1 receptor agonists (GLP-1RAs, incretin mimetics) and dipeptidyl
peptidase-4 inhibitors (DPP-4is, incretin enhancers) are glucose-lowering therapies with …

Diabetic retinopathy remains as a leading cause of blindness in developed countries.
Current treatments target late stages of DR when vision has already been significantly …

Diabetic retinopathy (DR) is an expanding global health problem, the exact mechanism of
which has not yet been clarified clearly, new insights into retinal physiology indicate that …

Diabetic foot ulcers (DFUs) are a severe complication of diabetes mellitus. Altered cell
migration due to microcirculatory deficiencies as well as excessive and prolonged reactive …

Wounds in diabetic patients, especially diabetic foot ulcers, are more difficult to heal
compared with normal wounds and can easily deteriorate, leading to amputation. Common …

The disease burden of diabetes mellitus (DM) and its associated cardiovascular
complications represent a growing and major global health problem. Recent studies suggest …

During recent years different types of adult stem/progenitor cells have been successfully
applied for the treatment of many pathologies, including cardiovascular diseases. The …

Diabetic retinopathy (DR) is a leading cause of visual impairment worldwide. Patients with
DR may irreversibly lose sight as a result of the development of diabetic macular edema …

Endothelial progenitors are a population of cells with the inherent capacity to differentiate
into mature endothelial cells and proangiogenic paracrine action. These characteristics …

Diabetes mellitus (DM) constitutes a chronic metabolic disease characterized by elevated
levels of blood glucose which can also lead to the so-called diabetic vascular complications …